C4 Therapeutics Inc (CCCC) — Free Cash Flow Generation Index

Latest as of June 2019: 0.98x

C4 Therapeutics Inc (CCCC) has a Free Cash Flow Generation Index of 0.98x as of June 2019. Free cash flow of $36.27 Million represents 1% of operating cash flow ($36.91 Million). Explore CCCC capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.

FCF Generation Index

0.98x
Free Cash Flow / Operating CF

Free Cash Flow

$36.27 Million
USD

Operating Cash Flow

$36.91 Million
USD

Capital Expenditures

$641.00K
USD

C4 Therapeutics Inc Free Cash Flow Generation Index (2019–2019)

Historical FCF Generation Index trend for C4 Therapeutics Inc across 1 annual periods. For the full cash flow conversion analysis, see how efficiently does C4 Therapeutics Inc generate cash.

Annual Free Cash Flow Generation for C4 Therapeutics Inc (2019–2019)

Year-by-year Free Cash Flow Generation Index for C4 Therapeutics Inc. Check CCCC cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.

Year FCG Index Free Cash Flow (USD) Operating CF Capital Expenditures YoY Change
2019 0.98x $54.27 Million $55.61 Million $1.35 Million
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).